FDA declines to issue specific guidance on health programs' foreign drug imports

A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S.
BioSpace

FDA’s 2027 Budget Proposes Permanent Rare Disease Vouchers, Easier Entry to Clinic

If the Trump administration’s proposal passes, the FDA’s budget will be more than $200 million bigger in 2027, with plans to ...
Fierce Pharma

FDA lays out policy wish list, including new trial pathway and new enforcement powers

One year into his tumultuous tenure as the FDA’s commissioner, Marty Makary, M.D., has laid out ambitious internal goals and ...
Regulatory Affairs Professionals Society

FDA budget proposal: New clinical trial pathway; permanent authorization of rare pediatric disease voucher program

The US Food and Drug Administration (FDA) has submitted its budget proposal to Congress, outlining its spending priorities ...
Hosted on MSN

Legal questions swirl around FDA's new expedited drug program, including who should sign off

WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
Medical News Today

FDA approves Wegovy-like GLP-1 pill, Foundayo, for weight loss

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...
Central MaineOpinion

The discount drug program Mainers rely on must be protected | Opinion

Pharmaceutical companies are spending hundreds of millions lobbying elected officials to try and persuade them to gut the ...